User profiles for "author:Sarah L Mason"

Sarah L Mason

University of Cambridge
Verified email at cam.ac.uk
Cited by 7948

Fetal dopaminergic transplantation trials and the future of neural grafting in Parkinson's disease

RA Barker, J Barrett, SL Mason, A Björklund - The Lancet Neurology, 2013 - thelancet.com
Clinical use of allografts of fetal ventral mesencephalic tissue as a treatment to replace
dopaminergic neurons in patients with Parkinson's disease was first done more than 20 …

Huntington's disease: Diagnosis and management

TB Stoker, SL Mason, JC Greenland, ST Holden… - Practical …, 2022 - pn.bmj.com
Huntington's disease (HD) is an inherited neurodegenerative disease characterised by
neuropsychiatric symptoms, a movement disorder (most commonly choreiform) and …

The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort

CH Williams-Gray, SL Mason, JR Evans… - Journal of Neurology …, 2013 - jnnp.bmj.com
Background Prognosis in Parkinson's disease (PD) remains poorly understood due to a lack
of unbiased data on the natural history of treated PD. The CamPaIGN study has been the …

Dopamine and Huntington's disease

LC Schwab, SN Garas, J Drouin-Ouellet… - Expert review of …, 2015 - Taylor & Francis
Huntington's disease (HD) is an incurable, inherited, progressive neurodegenerative
disorder that is defined by a combination of motor, cognitive and psychiatric features. Pre …

Glucocerebrosidase mutations influence the natural history of Parkinson's disease in a community-based incident cohort

SE Winder-Rhodes, JR Evans, M Ban, SL Mason… - Brain, 2013 - academic.oup.com
Carriers of mutations in the glucocerebrosidase gene (GBA) are at increased risk of
developing Parkinson's disease. The frequency of GBA mutations in unselected Parkinson's …

Microglial activation in regions related to cognitive function predicts disease onset in Huntington's disease: a multimodal imaging study

M Politis, N Pavese, YF Tai, L Kiferle… - Human brain …, 2011 - Wiley Online Library
Huntington's disease (HD) is an inherited neurodegenerative disorder associated with
motor, cognitive and psychiatric deficits. This study, using a multimodal imaging approach …

Cerebrovascular and blood–brain barrier impairments in Huntington's disease: potential implications for its pathophysiology

J Drouin‐Ouellet, SJ Sawiak, G Cisbani… - Annals of …, 2015 - Wiley Online Library
Objective Although the underlying cause of Huntington's disease (HD) is well established,
the actual pathophysiological processes involved remain to be fully elucidated. In other …

The natural history of treated Parkinson's disease in an incident, community based cohort

JR Evans, SL Mason, CH Williams-Gray… - Journal of Neurology …, 2011 - jnnp.bmj.com
Background Our understanding of the natural history of idiopathic Parkinson's disease (PD)
remains limited. In the era of potential disease modifying therapies, there is an urgent need …

[HTML][HTML] The Cambridge behavioural inventory revised

HJ Wear, CJ Wedderburn, E Mioshi… - Dementia & …, 2008 - SciELO Brasil
Neurobehavioural and psychiatric symptoms are common in a range of neurodegenerative
disorders with distinct profiles which are helpful in the diagnosis and monitoring of these …

Health‐related quality of life in Huntington's disease: which factors matter most?

AK Ho, AS Gilbert, SL Mason, AO Goodman… - Movement …, 2009 - Wiley Online Library
The aim of this article was to determine which aspects of Huntington's disease (HD) are most
important with regard to the health‐related quality of life (HrQOL) of patients with this …